Paracetamol With Caffeine to Treat Episodic Tension Type Headache

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Headache, Tension-Type
Interventions
DRUG

Placebo

Placebo

DRUG

Experimental paracetamol + caffeine formulation

experimental paracetamol + caffeine formulation

DRUG

ibuprofen marketed formulation

ibuprofen marketed formulation

DRUG

Paracetamol marketed formulation

Paracetamol marketed formulation

Trial Locations (7)

10550

Elkind Headache Center, Mount Vernon

10573

International Research Service, Inc., Port Chester

11042

Biomedical Research Alliance of New York LLC, Lake Success

19107

Jefferson Headache Center, Philadelphia

33024

University Clinical Research, Inc., Pembroke Pines

01104

Springfield Neurology Associates, Springfield

02481

MedVadis Research Corporation, Wellesley Hills

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY